MedPath

InvaGen Pharmaceuticals Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

FDA:3

Drug Approvals

clindamycin palmitate hydrochloride

Approval Date
Aug 26, 2020
FDA

Sevelamer carbonate

Approval Date
Oct 26, 2017
FDA

Nadolol

Approval Date
Aug 22, 2017
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.